Patient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSD

Psychiatric Services

Volumn 64, Issue 2, 2013, Pages 149-155

  Lund, Brian C ^a   Bernardy, Nancy C ^b,c   Vaughan Sarrazin, Mary ^a   Alexander, Bruce ^a   Friedman, Matthew J ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL CENTER FOR PTSD   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; ESZOPICLONE; PRAZOSIN; QUETIAPINE; RAMELTEON; TRAZODONE; ZALEPLON; ZOLPIDEM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; VETERAN; CLINICAL PRACTICE; DEMOGRAPHY; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; STATISTICS; UNITED STATES; VETERANS HEALTH;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; GUIDELINE ADHERENCE; HEALTH FACILITIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RESIDENCE CHARACTERISTICS; RISK ADJUSTMENT; STRESS DISORDERS, POST-TRAUMATIC; TRAZODONE; UNITED STATES; VETERANS; VETERANS HEALTH;

MLCS; MLOWN;

EID: 84880158376     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201200267     Document Type: Article

References (17)

1. Management of Post-Traumatic Stress. VA/DoD Clinical Practice Guideline. Washington, DC, US Veterans Health Administration, Department of Defense, 2010. Available at www.healthquality.va.gov/PTSDFULL-2010c.pdf. Accessed Dec 14, 2011
2. Post-Traumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care. Clinical Practice Guideline 26. London, National Institute for Health and Clinical Excellence, 2006. Available at guidance.nice.org.uk/CG26/Guidance. Accessed Dec 14, 2011
3. Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. Washington, DC, American Psychiatric Association, 2009. Available at psychiatryonline.org/content.aspx?bookid= 28§ionid=1682793. Accessed Dec 14, 2011
4. Lader M, Tylee A, Donoghue J: Withdrawing benzodiazepines in primary care. CNS Drugs 23:19-34, 2009
5. Hart G, Harris JA, Westbrook RF: Systemic or intra-amygdala injection of a benzodiazepine (midazolam) impairs extinction but spares re-extinction of conditioned fear responses. Learning and Memory 16: 53-61, 2009
6. Hart G, Harris JA, Westbrook RF: Systemic or intra-amygdala infusion of thebenzodiazepine, midazolam, impairs learning, but facilitates re-learning to inhibit fear responses in extinction. Learning and Memory 17:210-220, 2010
7. van Minnen A, Arntz A, Keijsers GPJ: Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout. Behaviour Research and Therapy 40:439-457, 2002
8. Lund BC, Bernardy NC, Alexander BA, et al: Declining benzodiazepine use in veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry 73:292-296, 2012
9. Bernardy NC, Lund BC, Alexander BA, et al: Prescribing trends in veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry 73:297-303, 2012
10. Mohamed S, Rosenheck RA: Pharmacotherapy of PTSD in the US Department of Veterans Affairs: diagnostic- and symptomguided drug selection. Journal of Clinical Psychiatry 69:959-965, 2008
11. Harpaz-Rotem I, Rosenheck RA: Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs. Archives of General Psychiatry 66: 417-421, 2009
12. Rural-Urban Commuting Area Codes. Washington, DC, US Department of Agriculture. Available at www.ers.usda.gov/data-products/rural-urban- commutingarea-codes.aspx. Accessed Dec 14, 2011
13. Fitzgerald LS, Hanlon JT, Shelton PS, et al: Reliability of a modified medication appropriateness index in ambulatory older persons. Annals of Pharmacotherapy 31: 543-548, 1997
14. Chrischilles EA, VanGilder R, Wright K, et al: Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. Journal of the American Geriatrics Society 57:1000-1006, 2009
15. Hansten PD, Horn JR: Hansten and Horn's Managing Clinically Important Drug Interactions. Vancouver, Wash, Applied Therapeutics, 1998
16. Lund BC, Chrischilles EA, Carter BL, et al: Development of a computer algorithm for defining an active drug list using an automated pharmacy database. Journal of Clinical Epidemiology 56:802-806, 2003
17. Lund BC, Charlton ME, Steinman MA, et al: Regional differences in prescribing quality among elder veterans and the impact of rural residence. Journal of Rural Health, ePub Aug 27, 2012; doi 10.1111/j.1748-0361.2012.00428